Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-11 4:00 pm Purchase |
2024-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 12,484,876 9.900% |
645,000 (+5.45%) |
Filing History |
| 2025-01-13 5:05 pm Sale |
2025-01-09 | 13D | Organogenesis Holdings Inc. ORGO |
Alan A. Ades | 22,319,836 17.800% |
-1 (-0.00%) |
Filing History |
| 2025-01-03 5:18 pm Unchanged |
2024-12-31 | 13D | Organogenesis Holdings Inc. ORGO |
Alan A. Ades | 22,319,837 17.800% |
0 (Unchanged) |
Filing History |
| 2024-11-19 4:05 pm Purchase |
2024-11-12 | 13D | Organogenesis Holdings Inc. ORGO |
Avista Healthcare Partners III L.P. | 28,680,359 18.000% |
28,680,359 (New Position) |
Filing History |
| 2024-11-14 8:09 pm Sale |
2024-11-12 | 13D | Organogenesis Holdings Inc. ORGO |
Alan A. Ades | 22,319,837 17.800% |
-4,055,909 (-15.38%) |
Filing History |
| 2024-11-14 3:35 pm Purchase |
2024-09-30 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 11,839,876 8.900% |
2,876,876 (+32.10%) |
Filing History |
| 2024-02-09 4:09 pm Purchase |
2023-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
MORGAN STANLEY MS |
11,505,331 8.700% |
11,505,331 (New Position) |
Filing History |
| 2024-02-02 09:54 am Purchase |
2023-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 8,963,000 6.800% |
1,599,937 (+21.73%) |
Filing History |
| 2023-04-06 09:29 am Sale |
2023-03-31 | 13G | Organogenesis Holdings Inc. ORGO |
BLACKROCK INC BLK |
4,488,613 3.400% |
-6,614,577 (-59.57%) |
Filing History |
| 2023-02-14 08:22 am Purchase |
2022-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 7,363,063 5.600% |
737,000 (+11.12%) |
Filing History |
| 2023-02-10 10:06 am Sale |
2022-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
Flynn James E | 0 0.000% |
-8,456,876 (Position Closed) |
Filing History |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
BLACKROCK INC BLK |
11,103,190 8.500% |
2,863,358 (+34.75%) |
Filing History |
| 2022-10-13 5:01 pm Purchase |
2022-10-11 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 6,626,063 5.100% |
6,626,063 (New Position) |
Filing History |
| 2022-02-11 4:12 pm Purchase |
2021-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
Flynn James E | 8,456,876 6.570% |
762,513 (+9.91%) |
Filing History |
| 2022-02-04 4:26 pm Purchase |
2021-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
BLACKROCK INC BLK |
8,239,832 6.400% |
8,239,832 (New Position) |
Filing History |
| 2021-12-30 4:21 pm Unchanged |
2021-12-28 | 13D | Organogenesis Holdings Inc. ORGO |
Alan A. Ades | 26,375,746 20.500% |
0 (Unchanged) |
Filing History |
| 2021-12-17 5:01 pm Unchanged |
2021-12-15 | 13D | Organogenesis Holdings Inc. ORGO |
Alan A. Ades | 26,375,746 20.500% |
0 (Unchanged) |
Filing History |
| 2021-07-09 4:57 pm Purchase |
2021-06-29 | 13G | Organogenesis Holdings Inc. ORGO |
Flynn James E | 7,694,363 6.000% |
7,694,363 (New Position) |
Filing History |
| 2021-05-28 9:28 pm Sale |
2021-05-27 | 13D | Organogenesis Holdings Inc. ORGO |
Alan A. Ades | 26,375,746 20.600% |
-3,887,500 (-12.85%) |
Filing History |
| 2021-05-26 5:59 pm Sale |
2021-05-26 | 13D | Organogenesis Holdings Inc. ORGO |
Avista Acquisition Corp. | 2,380,629 1.860% |
-6,484,744 (-73.15%) |
Filing History |